David Stoll, MD — Beverly Hills, California

David Stoll, MD is a clinical research site located in Beverly Hills, California, United States 90212.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

David Stoll, MD has participated in 2 clinical trials.

Therapeutic areas: Plaque Psoriasis, Psoriasis.

Sponsors: Galderma R&D, Wyeth is now a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for David Stoll, MD?

David Stoll, MD has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has David Stoll, MD conducted?

David Stoll, MD has 2 clinical trials on record. Their work covers Plaque Psoriasis, Psoriasis.

Is David Stoll, MD accredited by Crixeo Health?

David Stoll, MD has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about David Stoll, MD?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.